Tacrolimus therapy for refractory acute renal allograft rejection: A 4- year experience with an aggressive approach

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1234-1235

  Turner, C D ^a   Bruce, D S ^a   Cronin, D C ^a   Loss, G E ^a   Grewal, H ^a   Siegel, C ^a   Millis, J M ^a   Newell, K A ^a   Davis, B ^a   Todo, T ^a   Thistlethwaite, J R ^a   Woodle, E S ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OKT 3; TACROLIMUS;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; DEMOGRAPHY; DOSE RESPONSE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAINTENANCE THERAPY; MALE; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT PLANNING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AZATHIOPRINE; BIOPSY, NEEDLE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; SURVIVAL RATE; TACROLIMUS;

EID: 13144256706     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00223-1     Document Type: Conference Paper

References (7)

1. Jordan ML, Shapiro R, Jensen CWB, et al: Transplant Proc 23:3078, 1991
2. Jordan ML, Shapiro R, Vivas CA, et al: Transplantation 57:860, 1994
3. Woodle ES, Bruce DS, Josephson M, et al: Clin Transplant 10:323, 1996
4. Woodle ES, Thistlethwaite JR, Gordon JH, et al: Transplantation 62:594, 1996
5. Woodle ES, Cronin D, Newell KA, et al: Transplantation 62:1, 1196
6. Naraghi RM, Smith D, Shapiro R, et al: Transplant Proc 29:310, 1997
7. Solez K, Arelsen RA, Benedictsson H, et al: Kidney Int 44:411, 1993